The up to €750 million transaction gives Fresenius full ownership of the biosimilars platform, greater strategic control and an expected immediate benefit to Group core earnings per share IN BRIEFKEY TAKEAWAYSFAQs Fresenius SE & Co. KGaA has acquired the remaining … Read the full press release →
Posted in Business, Germany, Healthcare, Investment, Pharma & Biotech, Spain
Tagged #FutureFresenius, 45% stake acquisition, biopharmaceuticals, biosimilars, biosimilars market, CDMO, Dr. Sang-Jin Pak, Fresenius, Fresenius acquires final 45% of mAbxience as it scales Biopharma under #FutureFresenius, Fresenius completes full takeover of mAbxience and expands vertically integrated biosimilars platform, Fresenius Kabi, Fresenius SE & Co KGaA, Fresenius strengthens biosimilars strategy with full ownership of mAbxience and unchanged 2030 Biopharma ambition, Germany, Insud Pharma S.L., Invim Corporativo, S.L., Jurgen Van Broeck, mAbxience, mAbxience becomes wholly owned Fresenius business following up to €750 million transaction, mAbxience Holding S.L., Michael Sen, monoclonal antibodies, Spain, vertically integrated biopharma, €750 million acquisition
(IN BRIEF) Fresenius’ mAbxience has partnered with HP Inc. to co-develop an AI and digital-twin solution that can model and optimise biopharmaceutical manufacturing. The technology uses real plant data to simulate production scenarios, helping increase reliability, stabilise yields and shorten … Read the full press release →
Posted in Artificial Intelligence (AI), Business, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged AI collaboration, AI Collaboration Between mAbxience and HP Targets Smarter, Biopharma Innovation, bioprocess optimisation, biosimilars production, cell culture process, digital transformation, digital twin biomanufacturing, Fresenius, FutureFresenius strategy, HP Inc., industrial AI, León Spain, mAbxience, manufacturing efficiency, monoclonal antibodies, More Predictable Bioprocessing
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Digi Communications NV announces availability of Digi Spain’s H1 2026 financial results presentation
Load more...
